In-vitro diagnostic (IVD) solutions player Zhejiang Pushikang Biotechnology Co., Ltd. has pocketed ‘millions of dollars’ in a Series B round of financing led by YuanBio Venture Capital (also known as bioVenture), according to an announcement on Wednesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
